Literature DB >> 3002895

Fibrolamellar hepatocarcinoma: clinical, radiologic, and pathologic features.

I R Francis, F P Agha, N W Thompson, D F Keren.   

Abstract

Three new cases of an unusual subtype of hepatocellular carcinoma (HCC) referred to as fibrolamellar hepatocarcinoma (FLHC) recently seen at our institution are described. This report focuses on the clinical, radiologic, and pathologic features of this rare subset of HCC. All three patients were under 30 years of age with no previous history of hepatitis or cirrhosis. Each had had subacute symptoms for 5 months to 1 year before medical attention was sought and/or diagnosis of FLHC was established. There was no reliable correlation with oral contraceptive use in the 2 female patients. Serum alpha-1-fetoprotein levels were normal with only mild elevation of liver enzymes. The CT features, although not specific, were suggestive of an aggressive tumor with amorphous calcification in 2 of the 3 cases. Angiographically all tumors were hypervascular without any evidence of arterioportal shunting or venous invasion of major vessels. The clinical and radiologic recognition of these tumors is important since the surgical resectibility rate and 2- and 5-year survival rates are higher than those applicable to conventional HCC.

Entities:  

Mesh:

Year:  1986        PMID: 3002895     DOI: 10.1007/BF02035035

Source DB:  PubMed          Journal:  Gastrointest Radiol        ISSN: 0364-2356


  31 in total

1.  Fibrolamellar hepatocarcinoma: radiology, management, and pathology.

Authors:  L K Wong; D P Link; C F Frey; R H Ruebner; H Tesluk; N R Pimstone
Journal:  AJR Am J Roentgenol       Date:  1982-07       Impact factor: 3.959

2.  Histological evidence of carcinoma in a hepatic tumour associated with oral contraceptives.

Authors:  M Davis; B Portmann; M Searle; R Wright; R Williams
Journal:  Br Med J       Date:  1975-11-29

3.  The histopathologic and clinical indicators of prognosis in hepatoma.

Authors:  J J Chuong; E M Livstone; K W Barwick
Journal:  J Clin Gastroenterol       Date:  1982-12       Impact factor: 3.062

4.  Ground-glass cells in hepatocellular carcinoma.

Authors:  F W Stromeyer; K G Ishak; M A Gerber; T Mathew
Journal:  Am J Clin Pathol       Date:  1980-09       Impact factor: 2.493

5.  Hepatocellular carcinoma in women: probable lack of etiologic association with oral contraceptive steroids.

Authors:  Z D Goodman; K G Ishak
Journal:  Hepatology       Date:  1982 Jul-Aug       Impact factor: 17.425

6.  alpha-1-Antitrypsin phenotypes in hepatocellular carcinoma.

Authors:  S Govindarajan; M Ashcavai; R L Peters
Journal:  Hepatology       Date:  1981 Nov-Dec       Impact factor: 17.425

7.  Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features.

Authors:  J R Craig; R L Peters; H A Edmondson; M Omata
Journal:  Cancer       Date:  1980-07-15       Impact factor: 6.860

8.  Computed tomography of hepatocellular carcinoma.

Authors:  F Kunstlinger; M P Federle; A A Moss; W Marks
Journal:  AJR Am J Roentgenol       Date:  1980-03       Impact factor: 3.959

9.  Hepatocellular carcinoma in young people.

Authors:  D C Farhi; R H Shikes; P J Murari; S G Silverberg
Journal:  Cancer       Date:  1983-10-15       Impact factor: 6.860

10.  Imaging hepatic neoplasms.

Authors:  M E Bernardino; E Lewis
Journal:  Cancer       Date:  1982-12-01       Impact factor: 6.860

View more
  1 in total

1.  Functional expression of a proliferation-related ligand in hepatocellular carcinoma and its implications for neovascularization.

Authors:  Hiroshi Okano; Katsuya Shiraki; Yutaka Yamanaka; Hidekazu Inoue; Tomoyuki Kawakita; Yukiko Saitou; Yumi Yamaguchi; Naoyuki Enokimura; Keiichi Ito; Norihiko Yamamoto; Kazushi Sugimoto; Kazumoto Murata; Takeshi Nakano
Journal:  World J Gastroenterol       Date:  2005-08-14       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.